Target-Enhanced Whole-Genome Sequencing (TE-WGS) Shows Clinical Validity Equivalent to Commercially Available Targeted Oncology Panel.
Lee S, Roh J, Park JS, Tuncay IO, Lee W, Kim JA, Oh BB, Shin JY, Lee JS, Ju YS, Kim R, Park S, Koo J, Park H, Lim J, Connolly-Strong E, Kim TH, Choi YW, Ahn MS, Lee HW, Kim S, Kim JH, Kwon M.
Lee S, et al. Among authors: kim r, kim th, kim s, kim ja, kim jh.
Cancer Res Treat. 2024 Sep 19. doi: 10.4143/crt.2024.114. Online ahead of print.
Cancer Res Treat. 2024.
PMID: 39300929
Free article.